Swart JF - Search Results

1

Genomic Health Literacy Interventions in Pediatrics: Scoping Review.

Gupta A, Cafazzo JA, IJzerman MJ, Swart JF, Vastert S, Wulffraat NM, Benseler S, Marshall D, Yeung R, Twilt M. Gupta A, et al. Among authors: swart jf. J Med Internet Res. 2021 Dec 24;23(12):e26684. doi: 10.2196/26684. J Med Internet Res. 2021. PMID: 34951592 Free PMC article. Review.

2

Mesenchymal stem cells: a future for the treatment of arthritis?

Swart J, Martens A, Wulffraat N. Swart J, et al. Joint Bone Spine. 2008 Jul;75(4):379-82. doi: 10.1016/j.jbspin.2008.04.004. Epub 2008 Jun 16. Joint Bone Spine. 2008. PMID: 18558507 No abstract available.

3

Diagnostic workup for mixed connective tissue disease in childhood.

Swart JF, Wulffraat NM. Swart JF, et al. Isr Med Assoc J. 2008 Aug-Sep;10(8-9):650-2. Isr Med Assoc J. 2008. PMID: 18847172 Free article. Review.

4

The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis.

Swart JF, Barug D, Möhlmann M, Wulffraat NM. Swart JF, et al. Expert Opin Biol Ther. 2010 Dec;10(12):1743-52. doi: 10.1517/14712598.2010.532785. Epub 2010 Oct 28. Expert Opin Biol Ther. 2010. PMID: 20979564 Review.

5

Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010.

Otten MH, Prince FH, Twilt M, Ten Cate R, Armbrust W, Hoppenreijs EP, Koopman-Keemink Y, Wulffraat NM, Gorter SL, Dolman KM, Swart JF, van den Berg JM, van Rossum MA, van Suijlekom-Smit LW. Otten MH, et al. Among authors: swart jf. J Rheumatol. 2011 Oct;38(10):2258-63. doi: 10.3899/jrheum.110145. Epub 2011 Aug 15. J Rheumatol. 2011. PMID: 21844151

6

Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.

Otten MH, Prince FH, Armbrust W, ten Cate R, Hoppenreijs EP, Twilt M, Koopman-Keemink Y, Gorter SL, Dolman KM, Swart JF, van den Berg JM, Wulffraat NM, van Rossum MA, van Suijlekom-Smit LW. Otten MH, et al. Among authors: swart jf. JAMA. 2011 Dec 7;306(21):2340-7. doi: 10.1001/jama.2011.1671. Epub 2011 Nov 6. JAMA. 2011. PMID: 22056397

7

Changing winds in refractory autoimmune disease in children: clearing the road for tolerance with cellular therapies.

Swart JF, Lindemans CA, van Royen A, Boelens JJ, Prakken BJ, Wulffraat N. Swart JF, et al. Curr Opin Rheumatol. 2012 May;24(3):267-73. doi: 10.1097/BOR.0b013e32835264f4. Curr Opin Rheumatol. 2012. PMID: 22418744 Review.

8

What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?

Swart JF, de Roock S, Wulffraat NM. Swart JF, et al. Arthritis Res Ther. 2013;15(3):213. doi: 10.1186/ar4213. Arthritis Res Ther. 2013. PMID: 23731900 Free PMC article. Review.

9

Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?

Anink J, Otten MH, Gorter SL, Prince FH, van Rossum MA, van den Berg JM, van Pelt PA, Kamphuis S, Brinkman DM, Swen WA, Swart JF, Wulffraat NM, Dolman KM, Koopman-Keemink Y, Hoppenreijs EP, Armbrust W, ten Cate R, van Suijlekom-Smit LW. Anink J, et al. Among authors: swart jf. Rheumatology (Oxford). 2013 Sep;52(9):1674-9. doi: 10.1093/rheumatology/ket170. Epub 2013 Jun 4. Rheumatology (Oxford). 2013. PMID: 23740187

10

Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial.

Heijstek MW, Kamphuis S, Armbrust W, Swart J, Gorter S, de Vries LD, Smits GP, van Gageldonk PG, Berbers GA, Wulffraat NM. Heijstek MW, et al. JAMA. 2013 Jun 19;309(23):2449-56. doi: 10.1001/jama.2013.6768. JAMA. 2013. PMID: 23780457 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page